|
EquityInvest.com announces key relationship
with SerOptix, Inc. BOSTON, MA - August 23, 2001 -
EquityInvest.com, a webs leading company, specializing in assisting private
companies in need of venture capital to expand their businesses, and SerOptix, Inc., a
pioneer in
healthcare and biopharmaceutical applications of spectra-molecular informatics, have announced a key relationship
as signing new business agreement. Under terms of the new agreement,
EquityInvest.coms responsibility include optimizing a marketing plan, sharing
business development ideas, assisting in securing a corporate partner, introducing
individual and institutional investors to SerOptix, who will fund its current $7,500,000
private round of financing, and helping in the possible sale of SerOptix. EquityInvest.com
has taken another step to increase its presence on the web as launching networking venture
with SerOptix. We believe
that SerOptixs technology can make important contributions to the future of
healthcare practices and represents a technology with the true potential to broadly
benefit society, according to Milo Georgiev, Chairman and CEO of EquityInvest.com. We always will be loyal to
SerOptix. Stephen
Feldman, Chairman and CEO of the Board of SerOptix, Inc., said, Mr. Georgiev and
EquityInvest.com are important business consultants to the Company. Mr. Georgiev has
unique skills to help private companies seeking venture capital his team is always
available to us.
Important Factors Relating to
Forward-Looking Statements The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements so long as those statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those projected in such statements. All statements, including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend" and other similar expressions, constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. In connection with certain forward-looking statements contained in this press release and those that may be made in the future by or on behalf of EquityInvest.com, our companys representatives note that there are various factors that could cause actual results to differ materially from those set forth in any such forward-looking statements. The forward-looking statements contained in this press release were prepared by management and are qualified by, and subject to, significant business, economic, competitive, regulatory and other uncertainties and contingencies, all of which are difficult or impossible to predict and many of which are beyond the control of EquityInvest.com. Accordingly, there can be no assurance that the forward-looking statements contained in this press release will be realized or that actual results will not be significantly higher or lower. Readers of this press release should consider these facts in evaluating the information contained herein. In addition, the business and operations of the EquityInvest.com are subject to substantial risks, which increase the uncertainty inherent in the forward-looking statements contained in this press release. The inclusion of the forward-looking statements contained in this press release should not be regarded as a representation by EquityInvest.com or any other person that the forward-looking statements contained in the press release will be achieved. In light of the foregoing, readers of this press release are cautioned not to place undue reliance on the forward-looking statements contained herein.
|